Challenges are emerging with regard to the pre-clinical, regulatory assessment of display systems used for viewing and interpreting medical images. This article discusses those, and also the types of evidence that might be relevant to the evaluation of mobile image-viewing devices, true-color devices with applications in digital microscopy, and 3-D medical displays as discussed in Part 1.